|
Variables
|
Hazard ratio
|
95%CI
|
P value
|
|---|
|
ER (+) versus (-)
|
1.10
|
0.89 to 1.36
|
4.00E-01
|
|
Non-HER2/TN versus HER2+/TN
|
1.26
|
1.03 to 1.54
|
2.20E-02
|
|
Age <50 versus > = 50
|
0.85
|
0.74 to 0.96
|
1.10E-02
|
|
Size < =2 cm versus >2 cm
|
1.78
|
1.56 to 2.02
|
0.00E + 00
|
|
LN (-) versus (+)
|
0.68
|
0.60 to 0.77
|
8.20E-10
|
|
Grade1 versus 2
|
1.50
|
1.17 to 1.91
|
1.30E-03
|
|
Grade1 versus 3
|
1.40
|
1.09 to 1.81
|
9.80E-03
|
|
CMTC-1 versus 2
|
2.06
|
1.73 to 2.46
|
1.00E-15
|
|
CMTC-1 versus 3
|
2.01
|
1.62 to 2.50
|
3.30E-10
|
- CI, confidence interval; CMTC, ClinicoMolecular Triad Classification; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; LN, lymph node status; TN, triple-negative.
